In fact, the inhibition of the estrogenic receptors by treatment with tamoxifen, a substance that inhibits the binding of estrogen to its receptor, or ICI 182.780, an estrogen receptor antagonist, is considered one of the main strategies for the prevention and treatment of breast cancer [22]. Here, ESR1 is linked to breast cancer.